Start Your NewsReadery Pro FREE TRIAL!

Register and verify your email address to start your NewsReadery Pro FREE TRIAL today!

Login / Register

wallstreetpr.com / Share Newsitem

View, share or embed this newsitem using the details below.
Alzheimer's disease affects millions globally, with cases expected to double by 2060 to nearly 14 million adults against the backdrop of minimal treatment options In clinical trials today, Tiziana Life Sciences' intranasal Foralumab shows promise in
Continue
Please wait ...